When DeepSeek unveiled AI models rivaling America’s best at lower costs, it was seen as a sudden leap. However, a sweeping National Bureau of Economic Research (NBER) study of nearly 14 million patents suggests the real story lies in China’s academic institutions, which are now outperforming U.S. universities in critical technology fields.
The University Engine
Harvard Business School’s Josh Lerner and his team found that Chinese universities account for over 25% of the country’s inventions in fields like AI, hypersonics, and biotech. This is 8x the U.S. rate of 3.3%, where academic patenting is described as a "sideshow" compared to corporate R&D. Furthermore, the study undercuts the assumption that Beijing relies on returning U.S. talent; fewer than one in ten critical technology patents involve inventors with U.S. work experience.
Closing the Quality Gap
The research found no evidence that China’s patent boom sacrificed quality. The share of Chinese critical-technology patents containing "disruptive" technical language reached 16% by 2022, closing in on the American share of roughly 20%. This shift is reflected in global rankings: Zhejiang University recently took the top spot in the Nature Index, pushing Harvard to second (or third, when including the Chinese Academy of Sciences). Currently, nine of the top ten academic institutions globally are Chinese.
U.S. Funding at a Crossroads
As China’s R&D spending hit $1.03 trillion in 2024—surpassing the U.S. for the first time—the American federal research pipeline has faced significant strain. Since 2025, the Trump administration has cut or frozen over $3 billion in NIH and NSF grants. Analysts like Dan Wang of Eurasia Group warn that sanctioning individual "national champions" like Huawei overlooks China’s decentralized base of 18,000 "little giant" firms and vast university networks that drive technological upgrading.
